| 1997 |
HscB (Hsc20) is a J-type co-chaperone that stimulates the ATPase activity of Hsc66 (HscA) up to 3.8-fold in a concentration-dependent manner, establishing it as a regulatory cochaperone rather than an independent chaperone. |
ATPase activity assay with purified proteins; protein purification and characterization |
Protein science |
High |
9144776
|
| 1998 |
Hsc20 (HscB) functions solely as a regulatory cochaperone for Hsc66 and lacks intrinsic chaperone activity; it does not suppress protein aggregation unlike DnaJ. The nucleotide exchange factor GrpE does not stimulate Hsc66 ATPase, indicating Hsc66/Hsc20 and DnaK/DnaJ/GrpE are separate systems with nonoverlapping functions. |
Aggregation suppression assays with model substrates (rhodanese, citrate synthase, luciferase); ATPase cross-stimulation experiments |
Journal of bacteriology |
High |
9852006
|
| 1999 |
HscB (hscB gene product) is partially required for Fe-S cluster assembly in E. coli; inactivation of hscB had a partial but appreciable effect on production of some ferredoxins, while iscS, iscA, hscA, and fdx were strictly required. |
Genetic inactivation (truncation or stop-codon insertion) of individual isc operon genes; coexpression with reporter ferredoxins; holoferredoxin production assay |
Journal of biochemistry |
High |
10544286
|
| 2000 |
HscB (Hsc20) directly binds IscU (and IscU-Fe/S complex), enhances binding of IscU to Hsc66, and decreases the apparent Km for IscU stimulation of Hsc66 ATPase activity; together IscU and Hsc20 increase Hsc66 ATPase activity up to 480-fold. |
Surface plasmon resonance; isothermal titration calorimetry; steady-state ATPase assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
10869428
|
| 2000 |
Crystal structure of Hsc20 (HscB) from E. coli determined at 1.8 Å resolution: the protein consists of an N-terminal J-domain (residues 1–75) connected to a unique C-terminal three-helix bundle (residues 84–171) via a short loop; the two domains are held in fixed orientation by an extensive hydrophobic interface (~650 Ų), suggesting Hsc20 functions as a rigid scaffold for substrate targeting to Hsc66. |
X-ray crystallography (SIR + MAD phasing, 1.8 Å resolution) |
Journal of molecular biology |
High |
11124030
|
| 2001 |
Yeast Jac1 (ortholog of HscB/HSCB) is the J-protein partner of Ssq1 in mitochondrial Fe-S cluster biogenesis; reduced Jac1 activity decreases activities of Fe-S-containing enzymes and causes mitochondrial iron accumulation independent of oxidative damage, indicating a direct role in Fe-S cluster assembly. |
Genetic analysis of jac1 and ssq1 mutants; enzyme activity assays for Fe-S proteins; iron measurement in mitochondria |
Proceedings of the National Academy of Sciences of the United States of America |
High |
11171977 11273703
|
| 2003 |
The LPPVK motif of IscU (residues 99–103) is the primary recognition sequence for Hsc66 (HscA); alanine scanning mutagenesis showed Pro101, Val102, and Lys103 are most critical for Hsc66 binding and ATPase stimulation; Hsc20 (HscB) can target IscU mutants to Hsc66 even when their direct Hsc66-binding affinity is reduced, indicating HscB acts as a targeting factor independent of IscU's Hsc66-binding motif. |
Alanine mutagenesis scan; ATPase stimulation assays; isothermal titration calorimetry; affinity sensor (SPR) |
The Journal of biological chemistry |
High |
12871959
|
| 2004 |
HscB (Hsc20) interacts selectively with the ATP-bound (T-state) conformation of HscA; together with IscU it synergistically stimulates both the rate of ATP hydrolysis (~500-fold) and the T→R conformational transition (~60-fold) of HscA, establishing a mechanism for substrate capture; IscU also accelerates the R→T transition (~50-fold) to regenerate the low-affinity T-state. |
Single-turnover and rapid-mixing ATPase kinetics; affinity sensor binding studies; steady-state ATPase assays |
The Journal of biological chemistry |
High |
15485839
|
| 2006 |
HscA and HscB together stimulate [2Fe-2S] cluster transfer from IscU to apo-ferredoxin more than 20-fold in an ATP-dependent manner; cluster transfer requires both HscB and MgATP; HscB alone or MgADP does not stimulate transfer, demonstrating that ATP hydrolysis by HscA is required. |
In vitro cluster transfer assay monitored by CD and EPR spectroscopy; phosphate production measurement; KCl stimulation of ATPase |
Biochemistry |
High |
16964969
|
| 2008 |
ATP hydrolysis by HscA and the accompanying T→R conformational transition are required for catalysis of Fe-S cluster transfer; an ATPase-dead HscA(T212V) mutant cannot accelerate cluster transfer; addition of HscA+HscB+ATP causes a transient distortion of the IscU-bound [2Fe-2S] cluster CD spectrum coupled to ATP hydrolysis; a 1:1:1 HscA-HscB-IscU complex and a single ATP hydrolysis event are sufficient to elicit full chaperone effect on the cluster. |
Visible-region CD spectroscopy; in vitro cluster transfer assay; site-directed mutagenesis (HscA T212V); concentration-dependence studies under limiting conditions |
Biochemistry |
High |
18986169
|
| 2008 |
NMR-based solution structure of HscB (Hsc20) confirms it faithfully resembles the crystal structure; the IscU binding surface on HscB maps to a conserved hydrophobic patch in the C-terminal domain (L92, M93, L96, E97, E100, E104, F153); triple alanine mutants HscB(L92A,M93A,F153A) and HscB(E97A,E100A,E104A) showed decreased IscU binding; L92A,M93A,F153A also disrupted the allosteric interaction within the HscA·IscU·HscB ternary complex. |
NMR spectroscopy (15N relaxation, 1H-15N HSQC perturbation mapping, RDCs); site-directed mutagenesis; ITC for binding affinity; HscA ATPase stimulation assay |
Biochemistry |
High |
18702525
|
| 2008 |
Crystal structure of human HscB (HSCB/HSC20) at 3.0 Å resolution reveals an L-shaped protein resembling E. coli HscB; uniquely, human HscB has an N-terminal tetracysteine metal-binding domain (CWXCX(9-13)FCXXCXXXQ) that coordinates a metal ion in a rubredoxin-like structural fold; normal mode analysis indicates a scissors-like domain motion. |
X-ray crystallography (3.0 Å resolution); normal mode analysis |
The Journal of biological chemistry |
High |
18713742
|
| 2009 |
HscB (Hsc20) binds to and stabilizes the ordered (S) conformational state of IscU, as determined by NMR; the IscU-HscB binding interface involves the N-terminal beta-strands and C-terminal alpha-helix of IscU; the complex interconverts between two or more states at a rate faster than complex dissociation. |
NMR spectroscopy (1H-15N HSQC perturbation mapping of IscU upon HscB addition); use of stabilizing IscU D39A mutant as surrogate for ordered state |
Biochemistry |
High |
19492851
|
| 2010 |
Human HSC20 (HSCB) complements yeast Jac1p functionally; it localizes primarily to mitochondria in HeLa cells (with small extra-mitochondrial fraction); it interacts with human ISCU and HSPA9 (hHSP70); RNAi depletion of hHSC20 reduces activities of both mitochondrial and cytosolic Fe-S enzymes; the N-terminal cysteine-rich domain unique to metazoan HSC20 is important for its integrity and function. |
Yeast complementation; subcellular fractionation/immunofluorescence; co-immunoprecipitation; RNAi knockdown with enzyme activity assays; domain deletion analysis |
Human molecular genetics |
High |
20668094
|
| 2011 |
Human HSC20 interacts with frataxin in an iron-dependent manner; it also interacts with the ISCU/NFS1 ISC biogenesis complex and GRP75; knockdown of HSC20 reduces mitochondrial ISC enzyme activities and alters cytosolic and mitochondrial iron homeostasis (increased transferrin receptor 1 and IRP2 expression). |
Co-immunoprecipitation; siRNA knockdown with enzyme activity assays; iron pool measurements; western blotting |
Human molecular genetics |
Medium |
22171070
|
| 2011 |
Three hydrophobic residues in the C-terminal domain of E. coli HscB (L92, L96, F153) make the greatest individual contributions to IscU binding affinity; triple alanine substitution L92A/L96A/F153A would reduce HscB-IscU binding affinity by ~15,000-fold (ΔΔGb ≅ 5.7 kcal/mol). |
Isothermal titration calorimetry; NMR spectroscopy (binding confirmation); site-directed mutagenesis of individual residues |
BMC biochemistry |
High |
21269500
|
| 2012 |
Crystal structure of yeast Jac1 (HscB ortholog) determined; eight surface-exposed residues form the Isu1-binding surface; variants with all eight residues replaced by alanine cannot support growth of jac1-Δ yeast; replacement of three key residues causes partial loss of function with slow growth and reduced Fe-S enzyme activities, establishing that Jac1-Isu1 interaction is indispensable in vivo. |
X-ray crystallography; site-directed mutagenesis; yeast growth complementation assay; Fe-S enzyme activity assays; in vitro binding assays |
Journal of molecular biology |
High |
22306468
|
| 2012 |
HscB (J-protein) preferentially binds the structured (S) conformational state of IscU, whereas HscA (Hsp70) preferentially binds and stabilizes the dynamically disordered (D) state of IscU; HscA releases IscU upon ATP binding. This establishes a mechanism where cluster transfer is coupled to ATP hydrolysis, IscU conversion to the D-state, and HscB release. |
NMR spectroscopy (15N-HSQC monitoring of IscU conformational states upon chaperone binding); use of IscU conformational state-stabilizing mutants |
The Journal of biological chemistry |
High |
22782893
|
| 2013 |
Yeast Jac1 and cysteine desulfurase Nfs1 compete for binding to the same hydrophobic surface patch on Isu, indicating their binding is mutually exclusive; this competition is proposed to mediate the transition from Fe-S cluster assembly (Nfs1 bound) to Hsp70-mediated cluster transfer (Jac1 bound). |
In vitro binding assays with Isu hydrophobic patch mutants; competition binding assays between Jac1 and Nfs1; in vivo functional assays in yeast |
The Journal of biological chemistry |
High |
23946486
|
| 2013 |
Human HSC20 (HscB) binds preferentially to the structured (S) state of ISCU; human mtHSP70 (HSPA9) binds preferentially to the disordered (D) state; HSC20 accelerates the ATPase activity of mtHSP70 and this is further enhanced by ISCU; NFS1 also binds preferentially to the D-state of ISCU. |
NMR spectroscopy with ISCU conformational state-stabilizing mutants (D39V, N90A, D39A, H105A); ATPase activity assays |
The Journal of biological chemistry |
High |
23940031
|
| 2013 |
Drosophila Hsc20 loss-of-function (piggyBac insertion mutants) causes larval growth arrest, reduced aconitase and succinate dehydrogenase activities (Fe-S enzymes), and disrupted iron homeostasis with apparent mitochondrial iron accumulation, establishing an in vivo role for Hsc20 in Fe-S cluster biogenesis and iron homeostasis. |
Drosophila genetic mutant analysis; enzyme activity assays (aconitase, succinate dehydrogenase, isocitrate dehydrogenase); iron staining/ferritin expression analysis |
Journal of biological inorganic chemistry |
High |
23444034
|
| 2015 |
HscB binding to apoIscU slows the rate (but not equilibrium) of [2Fe-2S] cluster formation on IscU; this slowing depends on a 1:1 HscB:IscU complex and requires HscB residues that mediate IscU binding; in the presence of HscA and ATP, cluster transfer from HscB-bound IscU is rescued; HscB may modulate cluster biosynthesis rate depending on acceptor protein availability. |
Circular dichroism spectroscopy monitoring cluster assembly; Fe-S cluster reconstitution experiments; HscB mutant analysis; cluster transfer to apoferredoxin |
Journal of biological inorganic chemistry |
Medium |
26246371
|
| 2016 |
HscB interacts weakly with the cysteine desulfurase IscS; the binding site on HscB involves a region in the longer stem of the L-shaped molecule; the interacting surface on IscS overlaps with sites involved in binding ferredoxin and frataxin. |
Co-immunoprecipitation/pulldown; NMR/biophysical binding assays |
Frontiers in molecular biosciences |
Low |
27730125
|
| 2018 |
Cytosolic HSC20 (C-HSC20) facilitates Fe-S cluster delivery to cytosolic and nuclear Fe-S proteins by mediating complex formation between ISC components (ISCU1, NFS1) and the CIA targeting complex (CIAO1, FAM96B, MMS19), demonstrating a novel cytosolic de novo Fe-S biogenesis pathway in parallel to the mitochondrial ISC pathway. |
Co-immunoprecipitation; protein interaction studies; knockdown experiments with Fe-S enzyme activity assays; subcellular fractionation |
Human molecular genetics |
Medium |
29309586
|
| 2020 |
Mutations in HSCB (frameshift and rare promoter variant) cause congenital sideroblastic anemia (CSA); reduced HSCB expression impairs Fe-S cluster biogenesis; HSCB knockdown/deletion in K562 cells, zebrafish, and mice results in defective RBC hemoglobinization, siderocyte formation, and broader hematopoiesis defects. |
Patient genetic analysis; engineered K562 cells with patient-specific promoter variant; siRNA knockdown and CRISPR deletion; zebrafish and mouse models; Fe-S enzyme activity assays; hematological phenotyping |
The Journal of clinical investigation |
High |
32634119
|
| 2023 |
Human DjC20/HscB (HSCB) behaves as a slightly elongated monomer in solution; it binds one Zn2+ ion with very high affinity (1:1 stoichiometry) via its N-terminal zinc-finger domain; Zn2+ removal destabilizes the protein and is required for structural integrity; recombinant hDjC20 stimulates HSPA9 ATPase activity. |
Small-angle X-ray scattering (SAXS); SEC-MALS; metal chelation (EDTA/DTPA); thermal and chemical denaturation; ATPase stimulation assay |
Biochimica et biophysica acta. Proteins and proteomics |
Medium |
37871810
|
| 2024 |
HSCB can be phosphorylated by PI3K and in its phosphorylated form binds to TACC3, mediating proteasomal degradation of TACC3; this relieves TACC3-mediated cytoplasmic retention of FOG1, facilitating FOG1 nuclear translocation during erythropoiesis and megakaryopoiesis. This represents a Fe-S cluster delivery-independent function of HSCB. |
Co-immunoprecipitation; phosphorylation assays; proteasome inhibitor experiments; knockdown of HSCB in K562 cells and CD34+CD90+ HSCs; nuclear/cytoplasmic fractionation; differentiation assays |
eLife |
Medium |
38757931
|